Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Healthcare REIT (AHR) EBITDA (2016 - 2025)

Historic EBITDA for American Healthcare REIT (AHR) over the last 10 years, with Q3 2025 value amounting to $56.5 million.

  • American Healthcare REIT's EBITDA rose 157836.78% to $56.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 17910.06%. This contributed to the annual value of -$37.9 million for FY2024, which is 5053.77% up from last year.
  • Per American Healthcare REIT's latest filing, its EBITDA stood at $56.5 million for Q3 2025, which was up 157836.78% from $10.4 million recorded in Q2 2025.
  • American Healthcare REIT's 5-year EBITDA high stood at $56.5 million for Q3 2025, and its period low was -$47.1 million during Q4 2022.
  • Its 5-year average for EBITDA is -$10.0 million, with a median of -$7.9 million in 2021.
  • As far as peak fluctuations go, American Healthcare REIT's EBITDA tumbled by 77279.37% in 2023, and later surged by 157836.78% in 2025.
  • American Healthcare REIT's EBITDA (Quarter) stood at -$25.0 million in 2021, then crashed by 88.61% to -$47.1 million in 2022, then surged by 34.68% to -$30.8 million in 2023, then decreased by 4.46% to -$32.1 million in 2024, then soared by 275.89% to $56.5 million in 2025.
  • Its last three reported values are $56.5 million in Q3 2025, $10.4 million for Q2 2025, and -$6.7 million during Q1 2025.